Novo Nordisk A/S rose 1.38% in premarket trading. The positive movement in the stock price may be attributed to the overall optimistic market sentiment, as reported by LBBW-Analyst Andreas da Graça, who noted that despite geopolitical uncertainties, the market is dominated by optimism due to hopes of a resolution in the US-EU trade dispute.
Comments
No comments yet